Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details Narrative)

v3.20.2
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Mar. 31, 2020
Cato Research Ltd.      
Related party expense $ 124,800 $ 1,405,100  
Accounts payable and accrued expenses 422,800   $ 578,800
Pherin Pharmaceuticals, Inc.      
Accounts payable and accrued expenses 0   0
Consulting Agreement      
Research and development expense 15,000 $ 27,700  
Accounts payable and accrued expenses $ 15,000   $ 15,000